First‑in‑human phase 1/2a study launches in China and the US targeting advanced cancers HUTCHMED has initiated a global phase 1/2a clinical trial of HMPL‑A580, its second antibody‑targeted therapy ...
The family-owned massage center, founded in a single San Antonio studio in 2005, now operates three Austin and three San Antonio locations AUSTIN, TX, UNITED STATES ...
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a Phase I/IIa ...
HONG KONG, SHANGHAI & FLORHAM PARK, N.J. - HUTCHMED (NASDAQ:HCM; HKEX:13) has initiated a Phase I/IIa clinical trial of HMPL-A580 in patients with unresectable, advanced or metastatic solid tumors in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results